Teladoc Health, Inc. (NYSE:TDOC) Stock Holdings Raised by Monaco Asset Management SAM

Key Points

• Monaco Asset Management SAM increased its stake in Teladoc Health by 22%, acquiring an additional 90,000 shares, bringing their total holdings to 500,000 shares worth approximately $3.98 million.
• Institutional investors own 76.82% of Teladoc Health's stock, indicating strong institutional interest with several firms significantly increasing their positions in the first quarter.
• Teladoc Health's stock has seen a decline of 8.1%, currently trading at $7.54, with analysts providing a mixed outlook, suggesting a target price range between $7.00 and $9.67.

Monaco Asset Management SAM increased its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 22.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 500,000 shares of the health services provider's stock after buying an additional 90,000 shares during the quarter. Teladoc Health accounts for about 0.8% of Monaco Asset Management SAM's investment portfolio, making the stock its 13th largest position. Monaco Asset Management SAM owned 0.29% of Teladoc Health worth $3,980,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also modified their holdings of the company. Cambridge Investment Research Advisors Inc. boosted its position in shares of Teladoc Health by 60.8% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock worth $316,000 after purchasing an additional 15,030 shares during the last quarter. Golden State Wealth Management LLC increased its position in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares in the last quarter. Wedmont Private Capital increased its position in shares of Teladoc Health by 20.3% in the 1st quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock valued at $117,000 after buying an additional 2,715 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Teladoc Health by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after buying an additional 22,664 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its position in shares of Teladoc Health by 22.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock valued at $134,000 after buying an additional 2,662 shares in the last quarter. Institutional investors own 76.82% of the company's stock.

Teladoc Health Price Performance

TDOC traded down $0.27 on Friday, hitting $6.94. 8,689,573 shares of the company's stock were exchanged, compared to its average volume of 7,300,037. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The stock has a market cap of $1.23 billion, a price-to-earnings ratio of -5.83 and a beta of 1.76. The firm has a 50-day moving average price of $7.70 and a 200-day moving average price of $8.50. The company has a current ratio of 2.67, a quick ratio of 1.64 and a debt-to-equity ratio of 0.70.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. The company had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%. Teladoc Health's revenue for the quarter was down 1.6% compared to the same quarter last year. During the same quarter last year, the company earned ($0.38) EPS. As a group, equities analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Activity

In related news, insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $27,151.88. Following the completion of the sale, the insider owned 17,645 shares in the company, valued at approximately $121,044.70. This trade represents a 18.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Adam C. Vandervoort sold 5,808 shares of the stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the transaction, the insider owned 69,773 shares in the company, valued at $478,642.78. This trade represents a 7.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 18,656 shares of company stock valued at $128,189 over the last quarter. Corporate insiders own 0.58% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Canaccord Genuity Group cut their price objective on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Bank of America decreased their target price on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research report on Wednesday, May 28th. Wells Fargo & Company decreased their target price on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Jefferies Financial Group dropped their price target on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Finally, Truist Financial dropped their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research report on Tuesday, May 27th. Twelve investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $9.76.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.